Literature DB >> 3355864

Requirement of the collagenous domain for carbohydrate processing and secretion of a surfactant protein, SP-A.

M A O'Reilly1, L Nogee, J A Whitsett.   

Abstract

Two distinct intracellular forms of surfactant protein Mr = 35,000 (SP-A) were demonstrated in both purified type II epithelial cells and rat lung in vivo. High-mannose precursors of Mr = 30,000 and 34,000 comprised a significant fraction of intracellular SP-A in vivo and in vitro. A second intracellular pool was demonstrated in lamellar body enriched fractions, which contained endoglycosidase-H resistant, sialylated forms of SP-A. Intracellular transport and secretion of SP-A was not altered by inhibitors of carbohydrate processing. However, incubation of type II cells with alpha,alpha'-dipyridyl or cis-4-hydroxy-L-proline, agents which disrupt triple-helix formation within collagenous peptide domains, inhibited sialylation, intracellular transport to the lamellar body fraction and secretion. In the presence of either alpha,alpha'-dipyridyl or cis-4-hydroxy-L-proline, high mannose precursors accumulated intracellularly and were not secreted after 16-18 h. Thus, high-mannose precursors in proximal intracellular pool(s) and sialylated forms in lamellar body-enriched fractions represent two major intracellular storage forms of SP-A in vitro and in vivo. SP-A is routed by processes dependent upon the hydroxylation of the collagenous domain of the polypeptide. Transport and secretion of SP-A are not dependent upon the addition or processing of asparagine-linked carbohydrate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355864     DOI: 10.1016/0167-4889(88)90073-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Surfactant protein composition of lamellar bodies isolated from rat lung.

Authors:  M A Oosterlaken-Dijksterhuis; M van Eijk; B L van Buel; L M van Golde; H P Haagsman
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 2.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 3.  Pulmonary surfactant and its apoproteins.

Authors:  S Hawgood; J A Clements
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 4.  Surfactant and its role in the pathobiology of pulmonary infection.

Authors:  Jennifer R Glasser; Rama K Mallampalli
Journal:  Microbes Infect       Date:  2011-09-10       Impact factor: 2.700

Review 5.  Surfactant protein-A: new insights into an old protein--II.

Authors:  A R Kumar; J M Snyder
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

6.  A 60-kilodalton immunodominant glycoprotein is essential for cell wall integrity and the maintenance of cell shape in Streptococcus mutans.

Authors:  J S Chia; L Y Chang; C T Shun; Y Y Chang; Y G Tsay; J Y Chen
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Methylamine decreases trafficking and packaging of newly synthesized phosphatidylcholine in lamellar bodies in alveolar type II cells.

Authors:  A Chander; N Sen; A M Wu; S Higgins; S Wadsworth; A R Spitzer
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

8.  Human surfactant protein A2 gene mutations impair dimmer/trimer assembly leading to deficiency in protein sialylation and secretion.

Authors:  Yi Song; Guodong Fang; Haitao Shen; Hui Li; Wenbing Yang; Bing Pan; Guowei Huang; Guangyu Lin; Lian Ma; Belinda Willard; Jiang Gu; Lemin Zheng; Yongyu Wang
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.